TFRC and neoplasm: Common targets employed in cancer therapy are enzyme and receptors overexpressed in tumour cells such as transferrin receptor (TfR) [7], human epidermal growth factor receptor-2 [8], folic acid receptor (FaR) [9], and CD44 receptor [10].